Published in Proc Natl Acad Sci U S A on May 01, 1993
CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med (1998) 3.82
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature (2012) 3.48
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A (2005) 3.30
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci U S A (2004) 3.08
The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol (2009) 2.87
Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity (2000) 2.58
CCR7 signals are essential for cortex-medulla migration of developing thymocytes. J Exp Med (2004) 2.52
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun (2006) 2.20
T cell development in mice lacking the CD3-zeta/eta gene. EMBO J (1993) 1.84
Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest (1998) 1.76
Distinct temporal patterns of T cell receptor signaling during positive versus negative selection in situ. Sci Signal (2013) 1.63
The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. J Exp Med (1996) 1.56
T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS Biol (2003) 1.49
Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev (2010) 1.42
Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection. J Exp Med (2005) 1.34
Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses. J Virol (2005) 1.28
Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J Virol (1995) 1.27
Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans. Clin Diagn Lab Immunol (2003) 1.24
TOX provides a link between calcineurin activation and CD8 lineage commitment. J Exp Med (2004) 1.24
Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity. Proc Natl Acad Sci U S A (2004) 1.20
Age-dependent requirement for gammadelta T cells in the primary but not secondary protective immune response against an intestinal parasite. J Exp Med (2003) 1.07
Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. J Virol (2004) 1.06
NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol (2010) 1.04
Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J Immunol (2012) 1.03
Dampening of death pathways by schnurri-2 is essential for T-cell development. Nature (2011) 1.02
Thymocyte development in major histocompatibility complex-deficient mice: evidence for stochastic commitment to the CD4 and CD8 lineages. Proc Natl Acad Sci U S A (1993) 1.02
Constitutive CD8 expression allows inefficient maturation of CD4+ helper T cells in class II major histocompatibility complex mutant mice. J Exp Med (1994) 1.00
Thymic negative selection is functional in NOD mice. J Exp Med (2012) 1.00
Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells. Mucosal Immunol (2014) 0.97
Dynamic repositioning of CD4 and CD8 genes during T cell development. J Exp Med (2004) 0.96
Two distinct pathways of positive selection for thymocytes. Proc Natl Acad Sci U S A (1998) 0.96
Opposing chemokine gradients control human thymocyte migration in situ. J Clin Invest (2013) 0.94
Immunogenicity of human embryonic stem cells: can we achieve tolerance? Springer Semin Immunopathol (2004) 0.93
Developmental plasticity in schistosomes and other helminths. Int J Parasitol (2003) 0.92
A role for Ly108 in the induction of promyelocytic zinc finger transcription factor in developing thymocytes. J Immunol (2013) 0.91
Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC. Proc Natl Acad Sci U S A (2006) 0.91
CD8 coreceptor extinction in signaled CD4(+)CD8(+) thymocytes: coordinate roles for both transcriptional and posttranscriptional regulatory mechanisms in developing thymocytes. Mol Cell Biol (2000) 0.90
Regulation of receptor internalization by the major histocompatibility complex class I molecule. Proc Natl Acad Sci U S A (1994) 0.89
Characterization of Ly108 in the thymus: evidence for distinct properties of a novel form of Ly108. J Immunol (2012) 0.86
Human embryonic stem cells for myocardial regeneration. Heart Fail Rev (2003) 0.86
Dendritic cells and chemokine-directed migration in transplantation: where are we headed? Clin Lab Med (2008) 0.85
Phosphoinositide and inositol phosphate analysis in lymphocyte activation. Curr Protoc Immunol (2009) 0.85
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells. Stem Cells Transl Med (2015) 0.85
Dendritic cells and innate immunity in kidney transplantation. Kidney Int (2015) 0.84
Basal and antigen-induced exposure of the proline-rich sequence in CD3ε. J Immunol (2011) 0.84
H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection. J Exp Med (2000) 0.84
MHC-dependent desensitization of intrinsic anti-self reactivity. Cancer Immunol Immunother (2008) 0.83
Immunological barriers to stem-cell based cardiac repair. Stem Cell Rev (2011) 0.81
The role of LAT-PLCγ1 interaction in γδ T cell development and homeostasis. J Immunol (2014) 0.79
The Role of Immunogenicity in Cardiovascular Disease. World Heart J (2011) 0.77
Modulation of gene expression by alloimmune networks following murine heart transplantation. Mol Genet Genomics (2004) 0.76
Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy. Stem Cells Transl Med (2013) 0.76
Unexpected role of clathrin adaptor AP-1 in MHC-dependent positive selection of T cells. Proc Natl Acad Sci U S A (2010) 0.76
Update on pediatric heart transplantation. Long-term complications. Tex Heart Inst J (1997) 0.75
Generation of alphabeta T-cell receptor+ CD4- CD8+ cells in major histocompatibility complex class I-deficient mice upon activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Immunology (2000) 0.75
Induction of thymocyte positive selection does not convey immediate resistance to negative selection. Immunology (2002) 0.75
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25
Mice lacking MHC class II molecules. Cell (1991) 6.25
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med (1991) 4.49
MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science (1991) 3.93
Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med (1992) 3.63
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (1992) 3.50
Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature (1991) 3.36
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci U S A (1991) 2.68
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc Natl Acad Sci U S A (1986) 2.26
Genetically determined murine models of immunodeficiency. Annu Rev Immunol (1987) 1.98
Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells. J Exp Med (1992) 1.62
Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med (1992) 1.37
T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol Res (1989) 1.05
Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome"). J Pediatr (1990) 1.01
A phenotype or not: targeting genes in the immune system. Science (1992) 0.95
Cytokines. Poking holes in the network. Nature (1992) 0.87
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell (1992) 27.80
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Role for DNA methylation in genomic imprinting. Nature (1993) 12.65
Simplified mammalian DNA isolation procedure. Nucleic Acids Res (1991) 12.56
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14
HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J (1998) 10.08
Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity (2001) 9.45
An essential role for ectodomain shedding in mammalian development. Science (1998) 9.14
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet (2001) 8.64
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57
Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A (2000) 8.12
De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development (1996) 7.98
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66
Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25
MyoD or Myf-5 is required for the formation of skeletal muscle. Cell (1993) 7.14
WT-1 is required for early kidney development. Cell (1993) 7.05
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet (2001) 6.92
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet (1999) 6.69
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature (1994) 6.50
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science (1999) 6.37
Guided medication dosing for inpatients with renal insufficiency. JAMA (2001) 6.25
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res (2000) 6.14
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99
Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell (1992) 5.98
Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci U S A (2001) 5.76
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56
The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13
Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev (1997) 4.90
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73
Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science (1996) 4.61
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci U S A (2001) 4.60
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med (1991) 4.49
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med (2002) 4.47
Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature (1989) 4.46
Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev (2001) 4.45
Chromosomal position and activation of retroviral genomes inserted into the germ line of mice. Cell (1981) 4.42
De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature (1982) 4.42
Replicating SV40 molecules containing closed circular template DNA strands. Nat New Biol (1971) 4.36
DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet (2001) 4.35
Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol (2001) 4.34
Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell (1986) 4.32
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J (1997) 4.28
A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell (2000) 4.26
Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev (2000) 4.24
Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development (1996) 4.20
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 4.16
Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. Nature (1983) 4.14
The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14
Facial fractures and submental tracheal intubation. Anaesthesia (2002) 4.13
Epigenetic instability in ES cells and cloned mice. Science (2001) 4.08
Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc Natl Acad Sci U S A (1976) 4.07
The Australian Incident Monitoring Study. Crisis management--validation of an algorithm by analysis of 2000 incident reports. Anaesth Intensive Care (1993) 4.04
Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol (2001) 4.03
MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science (1991) 3.93
Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell (1992) 3.91
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev (1997) 3.83
Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem (1998) 3.83
Nuclear cloning and epigenetic reprogramming of the genome. Science (2001) 3.79
De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc Natl Acad Sci U S A (1982) 3.77
ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol (1998) 3.77
Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet (1995) 3.72
DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning. Proc Natl Acad Sci U S A (1981) 3.70
Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell (1992) 3.65
c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J (1999) 3.65
Requirement of FGF-4 for postimplantation mouse development. Science (1995) 3.64
Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature (1994) 3.64
The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61
DNA hypomethylation leads to elevated mutation rates. Nature (1998) 3.60
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
DNA methylation in Drosophila melanogaster. Nature (2000) 3.46
Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J Virol (1987) 3.45
Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature (1983) 3.43
Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev (2001) 3.39
Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature (1991) 3.36
Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev Dyn (1996) 3.34
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol (1992) 3.31
Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev (1996) 3.29
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J (1984) 3.28
Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature (1996) 3.27
Biology of HIF-1alpha. Cell Death Differ (2008) 3.24
A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev (1993) 3.21
Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol (2000) 3.20
Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05
Sequence database searches via de novo peptide sequencing by tandem mass spectrometry. Rapid Commun Mass Spectrom (1997) 3.03
Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (1983) 2.96